BioSpecifics Technologies Corp.
BSTC
BSTC was delisted on the 1st of December, 2020.
62 hedge funds and large institutions have $53.6M invested in BioSpecifics Technologies Corp. in 2014 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 23 increasing their positions, 12 reducing their positions, and 3 closing their positions.
567% more first-time investments, than exits
New positions opened: 20 | Existing positions closed: 3
92% more repeat investments, than reductions
Existing positions increased: 23 | Existing positions reduced: 12
38% more funds holding
Funds holding: 45 → 62 (+17)
20% more capital invested
Capital invested by funds: $44.7M → $53.6M (+$8.88M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
+$4.4M |
| 2 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$2.09M |
| 3 |
Renaissance Technologies
New York
|
+$1.36M |
| 4 |
Charles Schwab
San Francisco,
California
|
+$1.08M |
| 5 |
Morgan Stanley
New York
|
+$866K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RG
Redmile Group
San Francisco,
California
|
-$7.04M |
| 2 |
BA
BlackRock Advisors
Wilmington,
Delaware
|
-$814K |
| 3 |
NC
Northpointe Capital
Bloomfield Hills,
Michigan
|
-$744K |
| 4 |
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System
Harrisburg,
Pennsylvania
|
-$416K |
| 5 |
Franklin Resources
San Mateo,
California
|
-$193K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
51
US Bancorp
Minneapolis,
Minnesota
| $48K | – | – | – |
|
|
SGAM
52
Smith Group Asset Management
Dallas,
Texas
| $41K | – | – | – |
|
|
U
53
UBS
Zurich,
Switzerland
| $22K | -$55.6K | -2,134 | -72% |
|
54
AllianceBernstein
Nashville,
Tennessee
| $22K | +$18K | +691 | +634% |
|
55
Federated Hermes
Pittsburgh,
Pennsylvania
| $11K | +$10.5K | +402 | New |
|
|
VFA
56
Virtus Fund Advisers
Hartford,
Connecticut
| $8K | +$8.07K | +310 | New |
|
57
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
| $7K | -$1.35K | -52 | -17% |
|
58
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $5K | -$14.6K | -562 | -70% |
|
59
Royal Bank of Canada
Toronto,
Ontario, Canada
| $5K | +$5.21K | +200 | New |
|
60
Citigroup
New York
| $2K | +$1.46K | +56 | New |
|
61
Barclays
London,
United Kingdom
| $2K | +$2.08K | +80 | New |
|
|
OA
62
OFI Advisors
Philadelphia,
Pennsylvania
| $1K | – | – | – |
|
|
RG
63
Redmile Group
San Francisco,
California
| – | -$7.04M | -271,620 | Closed |
|
|
BJ
64
BlackRock Japan
Tokyo,
Japan
| – | -$119K | -4,579 | Closed |
|
65
BNP Paribas Financial Markets
Paris,
France
| – | -$4.41K | -186 | Closed |
|
BSTC Hedge Fund Activity: Q2 2014 in Review
62 of the 3,480 institutional investors tracked by Wall St. Rank reported a position in BioSpecifics Technologies Corp. (BSTC) for Q2 2014, worth a combined $53.6M — up 20% from $44.7M a quarter earlier.
Buyers outnumbered sellers: 20 funds opened new BSTC positions and 3 closed out — a net gain of 17 holders — while 23 added to existing stakes and 12 trimmed.
The largest buyer was Deerfield Management, opening a new position worth an estimated $4.4M. The largest seller was Redmile Group, exiting entirely with an estimated $7.04M sold.
- 62 institutional investors held BioSpecifics Technologies Corp. (BSTC) as of Q2 2014, up from 45 in Q1 2014.
- Funds reported $53.6M of BioSpecifics Technologies Corp. stock for Q2 2014, up 20% quarter-over-quarter.
- 20 funds opened new BioSpecifics Technologies Corp. positions in Q2 2014 and 3 closed out, a net change of +17 holders.
- The largest BioSpecifics Technologies Corp. buyer in Q2 2014 was Deerfield Management, an estimated $4.4M added.
- The largest BioSpecifics Technologies Corp. seller in Q2 2014 was Redmile Group, an estimated $7.04M sold.
Based on aggregated 13F filings for Q2 2014.